Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Livanova Plc OR Sh (LIVN)

Livanova Plc OR Sh (LIVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,444,546
  • Shares Outstanding, K 54,606
  • Annual Sales, $ 1,253 M
  • Annual Income, $ 63,230 K
  • EBIT $ 194 M
  • EBITDA $ 267 M
  • 60-Month Beta 1.02
  • Price/Sales 2.75
  • Price/Cash Flow 14.87
  • Price/Book 2.98

Options Overview Details

View History
  • Implied Volatility 40.07% (-0.45%)
  • Historical Volatility 46.10%
  • IV Percentile 29%
  • IV Rank 21.62%
  • IV High 73.43% on 04/11/25
  • IV Low 30.87% on 08/18/25
  • Expected Move (DTE 2) 1.74 (2.75%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 11
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 966
  • Open Int (30-Day) 933
  • Expected Range 61.58 to 65.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.67
  • Number of Estimates 2
  • High Estimate 0.67
  • Low Estimate 0.66
  • Prior Year 0.71
  • Growth Rate Est. (year over year) -5.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.37 +20.43%
on 11/18/25
65.57 -3.82%
on 12/11/25
+9.43 (+17.58%)
since 11/17/25
3-Month
48.82 +29.19%
on 11/06/25
65.57 -3.82%
on 12/11/25
+8.54 (+15.66%)
since 09/17/25
52-Week
32.48 +94.18%
on 04/09/25
65.57 -3.82%
on 12/11/25
+13.13 (+26.29%)
since 12/17/24

Most Recent Stories

More News
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting

Eight scientific posters demonstrate significant seizure reduction and improved outcomes with VNS Therapy in patients with Drug-Resistant Epilepsy

LIVN : 63.40 (+0.51%)
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effective December...

LIVN : 63.40 (+0.51%)
LivaNova to Present at Piper Sandler Healthcare Conference in December

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Alex Shvartsburg, Chief Financial Officer, will present a general business update during a fireside chat at...

LIVN : 63.40 (+0.51%)
LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services

– New patient implants assigned to New Technology Ambulatory Payment Classification 1580 – End-of-service procedures elevated to Level 5 APC ...

LIVN : 63.40 (+0.51%)
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day

Provides 2030 Targets for Revenue and EPS Growth

LIVN : 63.40 (+0.51%)
LivaNova: Q3 Earnings Snapshot

LivaNova: Q3 Earnings Snapshot

LIVN : 63.40 (+0.51%)
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance

– Delivered double-digit reported and organic revenue growth and continued operating margin expansion – Raised full-year 2025 revenue, adjusted earnings...

LIVN : 63.40 (+0.51%)
LivaNova to Present at Wolfe Research Healthcare Conference in November

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Vladimir Makatsaria, Chief Executive Officer, and Alex Shvartsburg, Chief Financial Officer, will present...

LIVN : 63.40 (+0.51%)
LivaNova to Announce Third-Quarter 2025 Results

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2025 results on Wed., Nov. 5, 2025, at 1 p.m. London time (8 a.m. Eastern...

LIVN : 63.40 (+0.51%)
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting

Company studies continue to show durability and retention of benefits for patients receiving proximal hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea

LIVN : 63.40 (+0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London,...

See More

Key Turning Points

3rd Resistance Point 65.07
2nd Resistance Point 64.53
1st Resistance Point 63.81
Last Price 63.40
1st Support Level 62.55
2nd Support Level 62.01
3rd Support Level 61.29

See More

52-Week High 65.57
Last Price 63.32
Fibonacci 61.8% 52.93
Fibonacci 50% 49.03
Fibonacci 38.2% 45.12
52-Week Low 32.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar